Skip to main content
Algernon Health Inc. logo

Algernon Health Inc. — Investor Relations & Filings

Ticker · AGN CSE Human health and social work activities
Open in API
Filings indexed 308 across all filing types
Latest filing 2024-12-23 Regulatory Filings
Country CA Canada
Listing CSE AGN

About Algernon Health Inc.

https://www.algernonhealth.com/

Algernon Health Inc. is a healthcare company focused on the provision of advanced diagnostic services, primarily through the establishment of medical clinics specializing in Alzheimer's disease. A key offering is the utilization of brain-optimized Positron Emission Tomography (PET) scanning technology for screening and imaging within a planned network of North American facilities. The company maintains a clinical-stage drug development and repurposing division, which investigates existing, approved drugs for new therapeutic applications targeting unmet global medical needs.

Recent filings

Filing Released Lang Actions
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-501F1 (a prescribed regulatory form) submitted to the Alberta Securities Commission detailing reporting issuer classification, trading periods, market values, and fee calculation. It is not an earnings release, annual or interim report, management discussion, nor an announcement of a meeting or vote. It represents a statutory regulatory filing under Canadian securities rules and does not fit a more specific category. Therefore it is classified as a Regulatory Filing (RNS).
2024-12-23 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-502F1 submitted to the Ontario Securities Commission detailing the calculation of participation fees for a reporting issuer. It is not a financial report or earnings release but a regulatory submission specific to securities commission fees. It does not fit into specific categories like annual or interim reports, dividends, governance, or capital changes. Thus it is classified as a general regulatory filing (RNS).
2024-12-23 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document is titled “Independent Auditors’ Report” followed by the complete consolidated financial statements for the years ended August 31, 2024 and 2023. It contains the auditor’s opinion, basis for opinion, audit responsibilities, and full IFRS financial statements—typical of a standalone audit report rather than a broader annual report or earnings release. Therefore, it matches the Audit Report / Information category. FY 2024
2024-12-23 English
News release - English.pdf
Regulatory Filings
2024-08-20 English
News release - English.pdf
Regulatory Filings
2024-08-13 English
News release - English.pdf
Regulatory Filings
2024-08-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.